Jd Pathological Labs Private Limited

Jd Pathological Labs Private Limited - healthcare in Paradeep, Orissa, India. FY 2026 financials and compliance.
CIN U74999OR2016PTC025705 Incorporated 24 August 2016 ROC Cuttack HQ Paradeep, Orissa, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2017
₹39,140
Latest filing
EBITDA · FY 2017
*****
In full report
Net profit · FY 2017
*****
In full report
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
-
Latest available

About Jd Pathological Labs Private Limited

Data last updated: 10 February 2026

Jd Pathological Labs Private Limited is a private limited company based in Paradeep, Orissa, India. It specialises in dentalcare, a part of the broader healthcare sector. Incorporated on 24 August 2016, the company has been in operation for over 10 years.

Registered with ROC Cuttack under CIN U74999OR2016PTC025705.

Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Aparna Das and Thokala Viswanth.

Office: Ohb/28 Madhuban, Paradeep, Orissa, India – 754142.

As per the financials filed for FY 2017, the company reported a revenue of ₹39,140.

The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company Details of Jd Pathological Labs Private Limited
CIN U74999OR2016PTC025705
Registration Number 025705
Incorporation Date 24 August 2016
ROC Cuttack
Listing Status Unlisted
Company Status Active
Compliance Status Active Non-Compliant
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Ohb/28 Madhuban, Paradeep, Orissa, India – 754142
  • Industry
    Healthcare, Dentalcare, Nursing, Pathology
Company report
Jd Pathological Labs Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Jd Pathological Labs Private Limited report

Financials, compliance, directors, charges, ownership and filings for Jd Pathological Labs Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Jd Pathological Labs Private Limited

Jd Pathological Labs Private Limited operates primarily in the hospital and medical care and professional, scientific and technical sectors. The company has 2 registered business activity segments, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
********* Hospital and Medical Care ********* Medical and dental practice, Nursing, pathology, blood bank services, etc. *********
********* Professional, Scientific and Technical ********* Other professional, scientific and technical activities *********

Auditor Details of Jd Pathological Labs Private Limited

Jd Pathological Labs Private Limited is audited by JITENDRAPURSTY&ASSOCIATES for the financial year 2017. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
JITENDRAPURSTY&ASSOCIATES blur-value blur-value blur-value

Board of Directors of Jd Pathological Labs Private Limited

Jd Pathological Labs Private Limited is governed by 4 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Aparna Das Director 24 Aug 2016 9 Years 10 Months Current
Thokala Viswanth Director 24 Aug 2016 9 Years 10 Months Current
Sidharth Sankar Das Director 24 Aug 2016 9 Years 10 Months Current
Anwesha Sahoo Director 24 Aug 2016 9 Years 10 Months Current

Financials of Jd Pathological Labs Private Limited

Jd Pathological Labs Private Limited reported revenue of ₹39,140 (up ) for FY 2017. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
₹39,140
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Jd Pathological Labs Private Limited

As of FY 2017, Jd Pathological Labs Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings Jd Pathological Labs Private Limited

Jd Pathological Labs Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Jd Pathological Labs Private Limited

View historical data on people associated with Jd Pathological Labs Private Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Jd Pathological Labs Private Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Jd Pathological Labs Private Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Jd Pathological Labs Private Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Jd Pathological Labs Private Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Jd Pathological Labs Private Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Jd Pathological Labs Private Limited

MSME Payment Delays by Jd Pathological Labs Private Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Jd Pathological Labs Private Limited

Subsidiaries & Group Companies of Jd Pathological Labs Private Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Jd Pathological Labs Private Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Jd Pathological Labs Private Limited

MCA Filings & Documents of Jd Pathological Labs Private Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Jd Pathological Labs Private Limited

Directors
24 Aug 2016
Aparna Das was appointed as a Director on 24 Aug 2016 & has been associated with this company since 9 years 10 months.
Directors
24 Aug 2016
Thokala Viswanth was appointed as a Director on 24 Aug 2016 & has been associated with this company since 9 years 10 months.
Directors
24 Aug 2016
Sidharth Sankar Das was appointed as a Director on 24 Aug 2016 & has been associated with this company since 9 years 10 months.
Directors
24 Aug 2016
Anwesha Sahoo was appointed as a Director on 24 Aug 2016 & has been associated with this company since 9 years 10 months.
Activity
24 Aug 2016
Jd Pathological Labs Private Limited was registered on 24 Aug 2016 with Roc Cuttack & aged 9 years 10 months as per MCA records.

Frequently Asked Questions about Jd Pathological Labs Private Limited

Jd Pathological Labs Private Limited is an active private limited company in the healthcare sector based in Paradeep, Orissa, India. It was incorporated on 24 August 2016 (10+ years old) and is registered under CIN U74999OR2016PTC025705.

Jd Pathological Labs Private Limited reported revenue of ₹39,140 for FY 2017.

The current directors of Jd Pathological Labs Private Limited are:

The primary industry of Jd Pathological Labs Private Limited is healthcare. The company specifically operates in dentalcare. The company is currently active in this sector.

Jd Pathological Labs Private Limited can be reached at the registered office: Ohb28 Madhuban, Paradeep, Orissa, India – 754142.

The authorised capital is ₹10 Lakh, and the paid-up capital is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available